Latest Articles

$7.5m NIH research to study how PFAS exposure contributes to liver and endometrial cancer - Innovation News Network

$7.5m NIH research to study how PFAS exposure contributes to liver and endometrial cancer Innovation News Network

Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer - CancerNetwork

Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer CancerNetwork

NIH awards $7.5 million to study whether “forever chemicals” increase the risk of liver and endometrial cancers - Keck School of Medicine of USC

NIH awards $7.5 million to study whether “forever chemicals” increase the risk of liver and endometrial cancers Keck School of Medicine of USC

Mismatch Repair Protein Expression in Endometrial Intraepithelial Neoplasia and Endometrial Carcinoma: Experience From a Tertiary Care Hospital - Cureus

Mismatch Repair Protein Expression in Endometrial Intraepithelial Neoplasia and Endometrial Carcinoma: Experience From a Tertiary Care Hospital Cureus

Lenvatinib Dose Reductions Help Sustain Therapy in Endometrial Cancer - CancerNetwork

Lenvatinib Dose Reductions Help Sustain Therapy in Endometrial Cancer CancerNetwork

NIH funds study of forever chemicals’ liver and endometrial cancer risks - Bioengineer.org

NIH funds study of forever chemicals’ liver and endometrial cancer risks Bioengineer.org

NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers - News-Medical

NIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancers News-Medical

Editorial: Endometriosis: a fertility perspective.

The role of SYNE1/2 variants as a potential predisposition factor for the onset of endometriosis.

Endometriosis (EM) is a chronic, inflammatory gynaecological disorder defined by the presence of endometrial-like tissue outside the uterine cavity, most frequently affecting the ovaries, peritoneum, and uterosacral ligaments. Despite its …

Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer - CancerNetwork

Lenvatinib Combo Holds Ground Against HER2 ADCs in Endometrial Cancer CancerNetwork